PANCREASE MT 2

vivus llc.🇨🇦 Health Canada

Approval Id: 4ee486fcd8af550b
Drug Approval Canada Name: PANCREASE MT 2
Product Name: PANCREASE MT 2
Status: Marketed
Status Date: 2020-12-21
Original Market Date: 2020-12-21
Din: 02503433
Drug Class: Human
Dosage Form: Capsule (Delayed Release)
Route Of Administration: Oral
Schedule: Prescription , Schedule D
Ahfs: 56:16.00
Atc Original: A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC)
Atc Name: a 09 aa 02
Aig Number: 0302964046
Company Name: vivus llc.
Company Address: 900 East Hamilton Avenue, Suite 550, Campbell, California, United States, 95008

AMYLASE

10850 UNIT

LIPASE

2600 UNIT

PROTEASE

6200 UNIT

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

4ee486fcd8af550b

Type

Standard